Biological atlas and tissue collection for severe obesity
Official title: Influence of the Glycemic and Ponderal Status on Tissues Gene Expression (Biological Tissue Collection)
Run by University Hospital, Lille · NCT01129297 · Data updated 2026-11-12
This project will collect blood and tissue samples from adults having abdominal surgery to test how obesity and diabetes change gene activity in tissues that control glucose and fat.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 1 site (Lille, Nord) |
| Status | Recruiting |
| Started | June 13, 2006 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT01129297 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 who are undergoing abdominal surgery (for example bariatric surgery, cholecystectomy, or parietal repair) and meet one of the four BMI/glucose-tolerance phenotype categories are ideal candidates.
✕Probably not a fit
People who are not having abdominal surgery or who fall outside the age, BMI, or glucose-tolerance criteria are unlikely to be eligible or to receive direct benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective cohort collects blood and surgical tissue samples from adults undergoing abdominal operations to study gene expression in tissues involved in glucose and lipid metabolism. Participants are placed into four phenotype groups by BMI and glucose tolerance (severe obesity with diabetes, severe obesity with glucose intolerance, severe obesity without diabetes, and normal-weight controls). The project uses whole-genome linkage, transcriptomics, and bioinformatics and compares human findings with relevant animal models to map genetic variants and affected pathways. Samples and linked clinical data will create a biological atlas of “diabesity” to support mechanistic and therapeutic research.
Why it matters
Potential benefit: If successful, the work could reveal gene-expression patterns and pathways that point to better-targeted treatments or prevention strategies for people with obesity-related diabetes.
How similar studies have gone: Other tissue biobanks and transcriptomic studies have previously identified gene-expression signatures linked to obesity and type 2 diabetes, so the general approach has produced useful insights though this integrated genomics-to-pathway atlas is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years * Indication of abdominal surgery requiring a laparotomy or laparoscopy for bariatric surgery, cholecystectomy, or parietal surgical * Phenotype corresponding to one of the following four cases : 1. Body Mass Index ≥ 35 kg/m2 and diabetes defined by a fasting blood glucose ≥ 7 mmol/l and/or ≥ to 11.1 mmol/l, 120 minutes after ingestion of glucose (hyperglycemia caused by oral route) 2. Body Mass Index ≥ 35 kg/m2 with intolerance glucose defined by a fasting blood glucose\> 6 mmol/L and \<7 mmol/l and/or\> 7.8 mmol/l and \<11.1 mmol/l , 120 minutes after ingestion of glucose (hyperglycemia caused by oral route) 3. Body Mass Index ≥ 35 kg/m2 without diabetes defined by a blood glucose ≤ 6 mmol/L and / or ≤ 7.8 mmol/l, 120 minutes after ingestion of glucose (hyperglycemia caused by oral route) 4. Body Mass Index \<27 kg/m2 without diabetes defined by a blood glucose ≤ 6 mmol/L and / or ≤ 7.8 mmol/l, 120 minutes after ingestion of glucose (hyperglycemia caused by oral route) 5)27 \<Body Mass Index \<35 kg/m2 without diabetes defined by a blood glucose ≤ 6 mmol/L and / or ≤ 7.8 mmol/l, 120 minutes after ingestion of glucose (hyperglycemia caused by oral route) Exclusion Criteria: * unable to receive clear information * refusal to sign the consent form * pathology associated judged by the surgeon, may increase the risk of adverse events related to sampling tissue
Where it's running
-
Lille University Hospital
Lille, Nord, France Recruiting
Study contacts
- Principal investigator: Francois PATTOU, MD PhD — University Hospital, Lille
- Study coordinator: Francois PATTOU, MD PhD
- Email: fpattou@univ-lille2.fr
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How GLP-1 in the brain responds to sugar in people of different weights
This study tests whether the gut hormone GLP-1 changes how the brain reacts to sugar in people with healthy weight and those with obesity.
-
Semaglutide's effects on heart and muscle mass
This project will use MRI scans and strength tests over 12 months to see if semaglutide changes body and heart muscle in adults starting the medication.
-
Sisters of Heart: community health worker support to improve heart health in migrant farmworker women
This trial tests whether peer support and help accessing community resources from community health workers can reduce stress and improve heart health measures in Spanish- or English-speaking migrant farmworker women aged 18–45.
-
Inspire HER: a heart-health and stress-support program for Black women
This project will test whether the Inspire HER lifestyle program helps Black women with higher heart disease risk improve heart health and manage stress.
-
Brain blood flow and lactate responses in people with and without obesity
This project will see if exercise changes brain blood flow and blood lactate in adults with and without obesity.
-
Program to prevent young onset diabetes using genetic and clinical assessments
This study is testing a program that uses genetic and health checks to help young adults at risk of diabetes prevent the disease and learn more about their health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.